Mangoceuticals (MGRX) Accumulated Depreciation & Amortization (2022 - 2026)
Mangoceuticals recorded quarterly Accumulated Depreciation & Amortization of $3518.0 in Q1 2026, up 7.65% quarter-over-quarter from $3268.0 in Q4 2025, and up 1307.2% year-over-year from $250.0 in Q1 2025.
Mangoceuticals' Accumulated Depreciation & Amortization history runs 5 years deep, the most recent figure standing at $3518.0 for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization rose 1307.2% year-over-year to $3518.0; the TTM figure through Mar 2026 stood at $3518.0 (up 1307.2% YoY), while the FY2025 annual figure was $3268.0, down 67.11% from the prior year.
- Accumulated Depreciation & Amortization came in at $3518.0 for Q1 2026 at Mangoceuticals, up from $3268.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $24889.0 in Q4 2023 to a low of -$109874.0 in Q1 2023.
- A 5-year average of -$1510.3 and a median of $4800.0 in 2023 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization jumped 2175.81% in 2023 and sank 95.98% in 2025, its largest moves.
- Mangoceuticals' Accumulated Depreciation & Amortization stood at -$1199.0 in 2022, then surged by 2175.81% to $24889.0 in 2023, then tumbled by 60.08% to $9936.0 in 2024, then sank by 67.11% to $3268.0 in 2025, then grew by 7.65% to $3518.0 in 2026.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $3518.0, $3268.0, and $758.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,518.00 |
| Mar 31, 2026 | 3,518.00 |
| Dec 31, 2025 | 3,268.00 |
| Dec 31, 2025 | 3,268.00 |
| Sep 30, 2025 | 758.00 |
| Sep 30, 2025 | 758.00 |
| Jun 30, 2025 | 502.00 |
| Jun 30, 2025 | 502.00 |
| Mar 31, 2025 | 250.00 |
| Mar 31, 2025 | 250.00 |
| Dec 31, 2024 | 9,936.00 |
| Dec 31, 2024 | 9,936.00 |
| Sep 30, 2024 | 9,681.00 |
| Sep 30, 2024 | 9,681.00 |
| Jun 30, 2024 | 6,224.00 |
| Jun 30, 2024 | 6,224.00 |
| Mar 31, 2024 | 6,224.00 |
| Mar 31, 2024 | 6,224.00 |
| Dec 31, 2023 | 24,889.00 |
| Dec 31, 2023 | 24,889.00 |
| Sep 30, 2023 | 18,597.00 |
| Sep 30, 2023 | 18,597.00 |
| Jun 30, 2023 | 6,082.00 |
| Jun 30, 2023 | 6,082.00 |
| Mar 31, 2023 | 4,883.00 |
| Mar 31, 2023 | 4,883.00 |
| Dec 31, 2022 | -112,437.00 |
| Dec 31, 2022 | -112,437.00 |